Group Leader/s

Head of lab
 

intro

The vasculature is responsible for the optimal distribution of nutrients and oxygen throughout the body and must therefore continuously adapt to the changing needs of the tissues. To do this, vascular networks must be remodeled, eliminating (by pruning) or expanding (by duplication) segments with too little or too much blood flow. Blood flow also regulates immune system cells by favoring their free movement and their contact, homing, firm adhesion or endothelial transmigration in different contexts. Our group has been working for years to elucidate the cellular basis and molecular mechanisms that govern vascular and immune responses during inflammation and how they may contribute to tissue repair. To this end, we have focused on the actions of membrane-anchored extracellular matrix metalloproteinases (MT-MMPs), a subfamily of proteases that can dynamically modify the extracellular matrix and the activity of membrane or soluble proteins, and in particular their impact on the behavior of endothelial cells as well as monocytes/macrophages. We are currently focused on delving into the actions of blood flow, MT-MMPs and new players in the remodeling of vascular networks and the intravascular crawling of patrolling monocytes, a subpopulation responsible for monitoring the integrity of the endothelium and combating foreign agents. To this end, we have developed innovative techniques for advanced microscopy and 3D image analysis, computational tools, in vitro flow assays and in vivo reporter mouse models. Our lines of research will improve the understanding of these processes and allow us to identify targets to: i) improve capillary perfusion and tissue repair in cardiovascular or inflammatory pathologies; and ii) boost immune activity to fight infections and tumor metastasis mainly in the lung.

 

Members

Alicia G. Arroyo's team
 
 

Funding

  1. Plan Nacional I+D+I (Ministerio de Ciencia e Innovación): Blood flow-dependent actions of MT-MMPs in health and disease 2.0. PID2020-112981RB-I00. 2021-2024. PI.
  2. BBVA Foundation: Imaging of Triple negative Breast cancer with specific miniaturized antibodies by ImmunoPET. PR[17]_BIO_IMG_0114. 2018-2021. Coordinator: M.A. Morcillo (CIEMAT). Collaborator.
  3. Sociedad Española de Inmunología (Micromecenazgo): Prevención de metástasis pulmonares por activación de leucocitos circulantes. 2019-2021. PI.
  4. Plan Nacional I+D+I (Ministerio de Economía, Industria y Competitividad): Blood flow-dependent actions of MT-MMPs in health and disease. SAF2017-83229-R; 2018-2021. PI.
  5. Plan Nacional I+D+I (Ministerio de Economía y Competitividad): Cellular and molecular players in inflammation-driven angiogenesis. SAF2014-52050-R; 2015-2017. PI.
  6. The European Union: Next generation training in cardiovascular research and innovation (CardioNext). MSCA: Initial Training Networks (ITN)/Innovative Doctoral Programme (IDP). PITN-GA-2013-608027; 2013-2017. Coordinator and PI.
  7. Plan Nacional I+D+I (Ministerio de Economía y Competitividad): Aortic aneurysm: from molecular mechanisms to new diagnostic and therapeutic approaches. Red de Enfermedades Cardiovasculares. RD12/0042/002; 2013-2016. PI.
  8. Fundación La Marató TV3: Targeting inflammation to improve heart repair and regeneration. 2013-2016. PI.
  9. Comunidad Autónoma de Madrid: Angiobodies 2.0: Desarrollo de anticuerpos recombinantes para uso terapéutico y diagnóstico en angiogénesis patológica y para la identificación de nuevos marcadores angiogénicos. S2010/BMD-2312; 2012-2016. PI.
  10. Plan Nacional I+D+I (Ministerio de Ciencia e Innovación): MT-MMPs and their substrates: a molecular roadmap for understanding inflammation-driven angiogenesis. SAF2011-25619; 2012-2014. PI.
 

More info

Patents

  1. Inhibitors of Membrane-type 4 matrix metalloproteinase (MT4-MMP) and its use in the treatment of diseases benefiting from an increase in the activity of patrolling monocytes. Inventors: Alicia G. Arroyo, C. Clemente, F. Martínez, R. A. Mota. Request nº EP17382735.3. Priority Country: European Patent Office. Request date: 3/11/2017. Entities: CNIC.
  1. Antibody Drug Conjugates. Inventors: María Garranzo García-Ibarrola, Andrés Francesch Solloso, Carmen Cuevas Marchante, María José Muñoz Alonso, Francisco Sánchez Madrid, Juan Manuel Zapata, Alicia G. Arroyo, Ángeles Ursa, Juan Manuel Domínguez Correa. Request nº. PCT/EP2014/061392. Priority Country: European Patent Office. Request date: 02/06/2014. Entities: Pharma Mar, Universidad Autónoma de Madrid.
  1. MT1-MMP substrates as biomarkers of inflammatory angiogenesis. Inventors: Alicia G. Arroyo, Agnieszka Koziol, Francesc Canals, Núria Colomé Calls, Joaquín Arribas. Request nº. EP11382255.5. Priority Country: European Patent Office. Request date: 26/07/2011. Entities: Centro Nacional de Investigaciones Cardiovasculares (CNIC), Institució Catalana de Recerca i Estudis Avançats (ICREA), Fundació Privada Institut d´Investigació Oncològica de Vall-Hebron (VHIO), Fundació Hospital Universitari Vall d´Hebron Institut de Recerca (VHIR).